TODAY'S NEWS
In a Dutch study published by de Blok et al in&nbs...
In a retrospective analysis published in Euro...
Colorectal cancer survivors’ risk for heart ...
In the phase III IMmotion151 trial reported in The...
In the phase III OPTIMISMM trial, reported by Rich...
More News From Today 
EDITORIALS & COMMENTARY
A number of immune checkpoint inhibitors (ICIs) have been approved by the FDA...
ES is a 41-year-old transgender male who presented to medical oncology as a referral...
In secondary data analysis (SDA) studies, investigators use data collected by other researchers...
Rucaparib and niraparib are two of the newest U.S. Food and Drug Administration–approved PARP inhibitors...
Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer...
More Editorials & Commentary 
